{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T04:18:13Z","timestamp":1792297093407,"version":"4.4.0"},"reference-count":22,"publisher":"Institute of Physiology of the Czech Academy of Sciences","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Physiol Res"],"published-print":{"date-parts":[[2025,4,30]]},"abstract":"<jats:p>Orthostatic intolerance (OI) is defined as the development of characteristic symptoms while standing, which significantly improve by recumbency. The most common forms are vasovagal syncope (VVS), orthostatic hypotension, and postural orthostatic tachycardia syndrome (POTS). Lately, there has been a growing body of evidence that autoimmunity may play a role in the pathophysiology of orthostatic intolerance syndromes. The aim was to compare the presence and levels of autoimmune autoantibodies in patients with POTS, VVS syncope, and the control group. Altogether, 61 patients with symptoms of orthostatic intolerance were evaluated in this study - 19 POTS patients and 42 VVS patients. The control group contained 22 patients with no signs of orthostatic intolerance. We evaluated levels of autoantibodies against three subtypes of G-protein coupled adrenergic receptor (alpha-1 and beta-1,2 adrenergic receptors), type 4 of muscarinic acetylcholine receptor, and angiotensin II type 1 receptor. We compared the levels between the three patient groups. Significantly higher levels of angiotensin II type 1 receptor (AT1R) autoantibodies were found in the POTS group compared with controls (0.67\u00b1 0.35 ng\/ml vs. 0.38\u00b10.32 ng\/ml, p=0.008). There was no significant difference in AT1R antibodies between the VVS and control groups (0.46\u00b10.34 ng\/ml vs 0.38\u00b10.32 ng\/ml, p= 0.38). Autoantibody concentration against ADRA1, ADRB1, ADRB2, and M4R were not significantly different between the groups. Autoimmune mechanisms may lead to abnormal regulation of the renin-angiotensin-aldosterone system and may contribute to the pathophysiology of POTS.<\/jats:p>","DOI":"10.33549\/physiolres.935504","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T20:09:07Z","timestamp":1747685347000},"page":"255-262","source":"Crossref","is-referenced-by-count":2,"title":["Autoimmune Antibodies in Orthostatic Intolerance Syndromes"],"prefix":"10.33549","author":[{"given":"M","family":"Luk\u00e1\u010dov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Mitro","sequence":"additional","affiliation":[{"name":"1st Department of Cardiology, VUSCH, P. J. Safarik University, Kosice, Slovakia. peter.mitro@upjs.sk"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Laz\u00farov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Hijov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Bertkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Valov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"19169","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Okamoto LE, Raj SR, Biaggioni I. Primer on the Autonomic Nervous System. In: Chronic Fatigue Syndrome and the Autonomic Nervous System. Robertson D (ed) 3rd edn. Academic Press, United States of America, 2012; pp 531-534. https:\/\/doi.org\/10.1016\/B978-0-12-386525-0.00110-4","DOI":"10.1016\/b978-0-12-386525-0.00110-4"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Sheldon RS, Grubb BP, Olshansky B, Shen W-K, Calkins H, Brignole M, Raj SR et al. 2015 Heart Rhythm Society Expert Consensus Statement on the Diagnosis and Treatment of Postural Tachycardia Syndrome, Inappropriate Sinus Tachycardia, and Vasovagal Syncope. Heart Rhythm 2015; 12; e41-e63. https:\/\/doi.org\/10.1016\/j.hrthm.2015.03.029","DOI":"10.1016\/j.hrthm.2015.03.029"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Kenny RA, McNicholas T. The management of vasovagal syncope. QJM 2016; 109; 767-773. https:\/\/doi.org\/10.1093\/qjmed\/hcw089","DOI":"10.1093\/qjmed\/hcw089"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Aboseif A, Bireley JD, Yuebing L, Polston D, Abbatemarco JR. Autoimmunity and postural orthostatic tachycardia syndrome: Implications in diagnosis and management. Cleve Clin J Med 2023; 90; 439-447. https:\/\/doi.org\/10.3949\/ccjm.90a.22093","DOI":"10.3949\/ccjm.90a.22093"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Olshansky B, Cannom D, Fedorowski A, Stewart J, Gibbons C, Sutton R, Shen W-K et al. Postural orthostatic tachycardia syndrome (POTS): A critical assessment. Prog Cardiovasc Dis 2020; 63; 263-270. https:\/\/doi.org\/10.1016\/j.pcad.2020.03.010","DOI":"10.1016\/j.pcad.2020.03.010"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Raj SR, Fedorowski A, Sheldon RS. Diagnosis and management of postural orthostatic tachycardia syndrome. CMAJ 2022; 14; 194. https:\/\/doi.org\/10.1503\/cmaj.211373","DOI":"10.1503\/cmaj.211373"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Yu X, Li H, Murphy TA, Nuss Z, Liles J, Liles C, Aston CE et al. Angiotensin II Type 1 Receptor Autoantibodies in Postural Tachycardia Syndrome. J Am Heart Assoc 2018; 7; 8. https:\/\/doi.org\/10.1161\/JAHA.117.008351","DOI":"10.1161\/jaha.117.008351"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Fedorowski A, Li H, Yu X, Koelsch KA, Harris VM, Liles C, Murphy TA et al. Antiadrenergic autoimmunity in postural tachycardia syndrome. Europace 2017; 19; 1211-1219. https:\/\/doi.org\/10.1093\/europace\/euw154","DOI":"10.1093\/europace\/euw154"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Wang XL, Chai Q, Charlesworth MC, Figueroa JJ, Shen W-K, Lee HC. Autoimmunoreactive IgGs from patients with postural orthostatic tachycardia syndrome. Proteomics Clin Appl 2012; 6; 615-625. https:\/\/doi.org\/10.1002\/prca.201200049","DOI":"10.1002\/prca.201200049"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Li H, Yu X, Liles C, Khan M, Vanderlinde-Wood M, Galloway A et al. Autoimmune Basis for Postural Tachycardia Syndrome. J Am Heart Assoc 2014; 3. https:\/\/doi.org\/10.1161\/JAHA.113.000755","DOI":"10.1161\/jaha.113.000755"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Goodman BP. Evaluation of postural tachycardia syndrome (POTS). Auton Neurosci 2018; 215; 12-19. https:\/\/doi.org\/10.1016\/j.autneu.2018.04.004","DOI":"10.1016\/j.autneu.2018.04.004"},{"key":"ref11","unstructured":"Lu CC, Tseng CJ, Tang HS, Tung CS. Orthostatic intolerance: Potential Pathophysiology and Therapy. Chin J Physiol 2004; 47; 101-109."},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Gunning WT, Kvale H, Kramer PM, Karabin BL, Grubb BP. Postural Orthostatic Tachycardia Syndrome Is Associated With Elevated G-Protein Coupled Receptor Autoantibodies. J Am Heart Assoc 2019; 8; 18. https:\/\/doi.org\/10.1161\/JAHA.119.013602","DOI":"10.1161\/jaha.119.013602"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Li H, Zuccolo J, Kem DC, Zillnes C, Lee J, Smith K, James JA et al. Implications of a Vasodilatory Human Monoclonal Autoantibody in Postural Hypotension. J Biol Chem 2013; 288; 30734-30741. https:\/\/doi.org\/10.1074\/jbc.M113.477869","DOI":"10.1074\/jbc.m113.477869"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Brignole M, Moya A, de Lange FJ, Deharo JC, Elliot PM, Faniciulli A, Fedorowski A et al. 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J 2018; 39; 1883-1948. https:\/\/doi.org\/10.5603\/KP.2018.0161","DOI":"10.5603\/kp.2018.0161"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Mustafa HI, Garland EM, Biaggioni I, Black BK, Dupont WD, Robertson D, Raj SR. Abnormalities of angiotensin regulation in postural tachycardia syndrome. Heart Rhythm 2011; 8; 422-428. https:\/\/doi.org\/10.1016\/j.hrthm.2010.11.009","DOI":"10.1016\/j.hrthm.2010.11.009"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Mustafa HI, Raj SR, Diedrich A, black BK, Paranjape SY, Dupont WD et al. Altered Systemic Hemodynamic & Baroreflex Response to Angiotensin II in Postural Tachycardia Syndrome. Circ Arrhythm Electrophysiol 2012; 5; 173-180. https:\/\/doi.org\/10.1161\/CIRCEP.111.965343","DOI":"10.1161\/circep.111.965343"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Spahic JM, Matisson IY, Hamrefors V, Johansson M, Ricci F, Nilsson J, Melander O et al. Evidence for Impaired Renin Activity in Postural Orthostatic Tachycardia Syndrome. J Clin Med 2023; 12; 4660. https:\/\/doi.org\/10.3390\/jcm12144660","DOI":"10.3390\/jcm12144660"},{"key":"ref18","unstructured":"Dubey J, Hopkins S, Vernino S. M1 and M2 muscarinic receptor antibodies among patients with postural orthostatic tachycardia syndrome: potential disease biomarker. J Clin Neuromuscul Dis 2016; 17; 179."},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Hall J, Bourne KM, Vernino S, Hamrefors V, Kharraziha I, Nilsson J, Sheldon RS et al. Detection of G Protein-Coupled Receptor Autoantibodies in Postural Orthostatic Tachycardia Syndrome Using Standard Methodology. Circulation. 2022; 146: 613-622. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.059971","DOI":"10.1161\/circulationaha.122.059971"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Li H, Zhang G, Zhou L, Nuss Z, Beel M, Hines B, Murphy T et al. Adrenergic Autoantibody-Induced Postural Tachycardia Syndrome in Rabbits. J Am Heart Assoc 2019; 8; 19. https:\/\/doi.org\/10.1161\/JAHA.119.013006","DOI":"10.1161\/jaha.119.013006"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Vernino S, Stiles L. Autoimmunity in Postural Orthostatic Tachycardia Syndrome: Current Understanding. Auton Neurosci 2018; 215; 78-82. https:\/\/doi.org\/10.1016\/j.autneu.2018.04.005","DOI":"10.1016\/j.autneu.2018.04.005"}],"container-title":["Physiological Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T20:09:09Z","timestamp":1747685349000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.biomed.cas.cz\/physiolres\/pdf\/2025\/74_255.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":22,"URL":"https:\/\/doi.org\/10.33549\/physiolres.935504","relation":{},"ISSN":["1802-9973","0862-8408"],"issn-type":[{"value":"1802-9973","type":"electronic"},{"value":"0862-8408","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,30]]}}}